Arcoma AB (STO:ARCOMA)
8.50
0.00 (0.00%)
Mar 2, 2026, 2:33 PM CET
Arcoma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 35.32 | 13.38 | 5 | 9.66 | 4.83 |
Cash & Short-Term Investments | 35.32 | 13.38 | 5 | 9.66 | 4.83 |
Cash Growth | 164.03% | 167.47% | -48.23% | 99.92% | -43.70% |
Accounts Receivable | 13.23 | 15.43 | 16.72 | 24.93 | 15.81 |
Other Receivables | 1.87 | 2.96 | 3.24 | 2.83 | 1.58 |
Receivables | 15.1 | 18.39 | 19.95 | 27.76 | 17.39 |
Inventory | 23.63 | 23.94 | 28.03 | 28.3 | 19.79 |
Prepaid Expenses | 2.52 | 1.68 | 1.68 | 1.2 | 1.21 |
Other Current Assets | 0 | - | - | - | - |
Total Current Assets | 76.56 | 57.38 | 54.66 | 66.93 | 43.22 |
Property, Plant & Equipment | 1.13 | 1.14 | 1.39 | 1.64 | 1.89 |
Goodwill | - | - | 0.67 | 2.01 | 3.35 |
Long-Term Deferred Tax Assets | 2.18 | 3.45 | 6.04 | 6.61 | 6.83 |
Long-Term Deferred Charges | 16.78 | 18.49 | 18.73 | 22.67 | 23.51 |
Other Long-Term Assets | - | - | 0.48 | 0.48 | 0.48 |
Total Assets | 96.65 | 80.46 | 81.96 | 100.33 | 79.27 |
Accounts Payable | 15.53 | 14.21 | 21.44 | 23.14 | 12.24 |
Accrued Expenses | 5.52 | 4.22 | 4.33 | 3.38 | 3.53 |
Short-Term Debt | - | - | - | 18.28 | 9.93 |
Current Portion of Long-Term Debt | - | - | 1.95 | 2.94 | 4.87 |
Current Portion of Leases | - | 0.06 | 0.09 | 0.11 | 0.83 |
Other Current Liabilities | 0.88 | 2.64 | 3.4 | 2.54 | 1.61 |
Total Current Liabilities | 21.92 | 21.13 | 31.2 | 50.39 | 33.01 |
Long-Term Debt | - | - | 1.93 | 3.87 | 1.81 |
Other Long-Term Liabilities | - | - | 0.18 | 0.19 | 0.41 |
Total Liabilities | 21.92 | 21.13 | 33.31 | 54.46 | 35.23 |
Common Stock | 28.62 | 26.37 | 26.37 | 26.37 | 26.1 |
Additional Paid-In Capital | 3.75 | 3.75 | 3.75 | 3.75 | 3.75 |
Comprehensive Income & Other | 42.37 | 29.22 | 18.54 | 15.76 | 14.19 |
Shareholders' Equity | 74.73 | 59.33 | 48.66 | 45.88 | 44.04 |
Total Liabilities & Equity | 96.65 | 80.46 | 81.96 | 100.33 | 79.27 |
Total Debt | - | 0.06 | 3.96 | 25.21 | 17.44 |
Net Cash (Debt) | 35.32 | 13.32 | 1.04 | -15.55 | -12.61 |
Net Cash Growth | 165.20% | 1179.25% | - | - | - |
Net Cash Per Share | 2.46 | 1.01 | 0.08 | -1.19 | -0.97 |
Filing Date Shares Outstanding | 14.31 | 13.19 | 13.19 | 13.19 | 13.05 |
Total Common Shares Outstanding | 14.31 | 13.19 | 13.19 | 13.19 | 13.05 |
Working Capital | 54.64 | 36.25 | 23.45 | 16.53 | 10.21 |
Book Value Per Share | 5.22 | 4.50 | 3.69 | 3.48 | 3.37 |
Tangible Book Value | 74.73 | 59.33 | 47.99 | 43.87 | 40.69 |
Tangible Book Value Per Share | 5.22 | 4.50 | 3.64 | 3.33 | 3.12 |
Machinery | - | 12.23 | 12.24 | 12.24 | 12.22 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.